IAS 2017 IASconference Funding stigma reduction for key

  • Slides: 7
Download presentation
#IAS 2017 | @IAS_conference Funding stigma reduction for key populations: innovation and actions Kate

#IAS 2017 | @IAS_conference Funding stigma reduction for key populations: innovation and actions Kate Thomson Head, Community, Rights and Gender and Civil Society Hub The Global Fund to fight AIDS, Tuberculosis

#IAS 2017 | @IAS_conference Funding stigma reduction for key populations: innovation and actions •

#IAS 2017 | @IAS_conference Funding stigma reduction for key populations: innovation and actions • Background and context • Funding stigma reduction as part of comprehensive packages for key populations • Innovative programmatic examples to reduce stigma and discrimination toward key populations funded through the Global Fund and partners • Action needed

#IAS 2017 | @IAS_conference Background and context • Human rights related barriers to services

#IAS 2017 | @IAS_conference Background and context • Human rights related barriers to services reduce impact of investments in HIV and health programs • Inadequate investment in programs to address stigma and discrimination and increase access to justice is evident - Lessons learned from 2014 – 2016 GF Funding Model • The Global Fund new Strategy 2017 – 2022 presents a unique opportunity to do better • The Global Fund is evolving its model to support Strategy implementation

#IAS 2017 | @IAS_conference Funding stigma reduction as part of comprehensive package for key

#IAS 2017 | @IAS_conference Funding stigma reduction as part of comprehensive package for key populations • Stigma & Discrimination reduction is one of the UNAIDS key 7 Programs to Address Stigma and Discrimination and Increase Access to Justice • Stigma & discrimination reduction as part of comprehensive packages of services for key populations

#IAS 2017 | @IAS_conference Innovative programmatic examples to reduce stigma and discriminations funded through

#IAS 2017 | @IAS_conference Innovative programmatic examples to reduce stigma and discriminations funded through the Global Fund and partners • Partnership with civil society organizations to provide training to health providers to meet the needs of key populations (e. g. Health 4 Men by Anova Health Institute) • Partnership with technical agencies to enhance and develop competency of clinicians and CBO staff providing care to and with key populations (e. g. UNDP Multi-Country South Asia HIV Programme Phase II) • Partnership with media, civil society and key population-led networks to change attitude towards key populations (e. g. HIVOS Multi-Country

#IAS 2017 | @IAS_conference Action needed • Adequately invest and bring programs to scale

#IAS 2017 | @IAS_conference Action needed • Adequately invest and bring programs to scale • Implement programs to increase sensitivity and competency of clinicians providing care to and with key populations as part of comprehensive programs for key populations • Ensure meaningful partnerships and engagement with key populations-led groups, networks and organizations in program design and delivery • Make facility-based services more acceptable, accessible, affordable and equitable • Ensure sustainability of efforts as part of long-term investments in human resources for health

#IAS 2017 | @IAS_conference Thank you

#IAS 2017 | @IAS_conference Thank you

IAS 2017 IASconference A Demonstration Open Label StudyIAS 2017 IASconference A Demonstration Open Label Study
IAS 2017 IASconference Interventions to Reduce Immune ActivationIAS 2017 IASconference Interventions to Reduce Immune Activation
IAS 2017 IASconference Rapporteur Report Track A BasicIAS 2017 IASconference Rapporteur Report Track A Basic
IAS 2017 IASconference Dr Sharon Kapambwe National CoordinatorIAS 2017 IASconference Dr Sharon Kapambwe National Coordinator
IAS 2017 IASconference Increasing HIV test uptake caseIAS 2017 IASconference Increasing HIV test uptake case
IAS 2017 IASconference Economic evaluation of nonfinancial incentivesIAS 2017 IASconference Economic evaluation of nonfinancial incentives
IAS 2017 IASconference MOSY 07 HIV Drug ResistanceIAS 2017 IASconference MOSY 07 HIV Drug Resistance
IAS 2017 IASconference Highrisk vaccinespecific HPV infection inIAS 2017 IASconference Highrisk vaccinespecific HPV infection in
IAS 2017 IASconference Conflict of Interest No conflictsIAS 2017 IASconference Conflict of Interest No conflicts
IAS 2017 IASconference Fast Track Cities IAPAC EndingIAS 2017 IASconference Fast Track Cities IAPAC Ending
IAS 2017 IASconference Global Overview of the MicrobiomeIAS 2017 IASconference Global Overview of the Microbiome
IAS 2017 IASconference ENDING HIV TRANSMISSION ALONG PEOPLEIAS 2017 IASconference ENDING HIV TRANSMISSION ALONG PEOPLE
IAS 2017 IASconference Youth Power Action funded andIAS 2017 IASconference Youth Power Action funded and
IAS 2017 IASconference Incidence of tuberculosis in theIAS 2017 IASconference Incidence of tuberculosis in the
IAS 2017 IASconference Efficacy of dual therapy withIAS 2017 IASconference Efficacy of dual therapy with
IAS 2017 IASconference Partner notification of sexually transmittedIAS 2017 IASconference Partner notification of sexually transmitted
IAS 2017 IASconference Conflict of Interest No conflictsIAS 2017 IASconference Conflict of Interest No conflicts
IAS 2017 IASconference Conflict of Interest No conflictsIAS 2017 IASconference Conflict of Interest No conflicts
IAS 2017 IASconference Should we fear antibiotic resistanceIAS 2017 IASconference Should we fear antibiotic resistance
IAS 2017 IASconference Fast Track Cities IAPAC NAIROBISIAS 2017 IASconference Fast Track Cities IAPAC NAIROBIS
IAS 2017 IASconference MOPDB 0101 More and earlierIAS 2017 IASconference MOPDB 0101 More and earlier
IAS 2017 IASconference HIV Drug Resistance HIVDR andIAS 2017 IASconference HIV Drug Resistance HIVDR and
IAS 2017 IASconference Conflict of Interest No conflictsIAS 2017 IASconference Conflict of Interest No conflicts
IAS 2017 IASconference Performance and usability of INSTIIAS 2017 IASconference Performance and usability of INSTI
IAS 2017 IASconference Evaluating the Implementation and ImpactIAS 2017 IASconference Evaluating the Implementation and Impact
IAS 2017 IASconference Providing youth friendly services toIAS 2017 IASconference Providing youth friendly services to
IAS 2017 IASconference HIV selftesting feasibility and acceptabilityIAS 2017 IASconference HIV selftesting feasibility and acceptability
IAS 2017 IASconference Selftesting an effective means ofIAS 2017 IASconference Selftesting an effective means of
IAS 2017 IASconference Monoclonal Antibodies for HIV PreventionIAS 2017 IASconference Monoclonal Antibodies for HIV Prevention
IAS 2017 IASconference Evaluation of tolerability pharmacokinetics andIAS 2017 IASconference Evaluation of tolerability pharmacokinetics and
Understanding Abortion Stigma STIGMA 101 o Key definitionsUnderstanding Abortion Stigma STIGMA 101 o Key definitions
Stigma and Recidivism How Stigma Effects an ExStigma and Recidivism How Stigma Effects an Ex
STIGMA and Mental Illness Himalee Abeya Stigma theySTIGMA and Mental Illness Himalee Abeya Stigma they
Stigma autisme INLEIDING DOOR ROLAND ANGENENT Definities StigmaStigma autisme INLEIDING DOOR ROLAND ANGENENT Definities Stigma
Understanding Stigma The impact of stigma and discriminationUnderstanding Stigma The impact of stigma and discrimination
The Stigma of Mental Illness Stigma A signThe Stigma of Mental Illness Stigma A sign
BREAKING THE CYCLE STIGMA DISCRIMINATION AND INTERNAL STIGMABREAKING THE CYCLE STIGMA DISCRIMINATION AND INTERNAL STIGMA
SNAP AND STIGMA 1 ADDRESSING STIGMA Getting theSNAP AND STIGMA 1 ADDRESSING STIGMA Getting the